Observational studyClinical therapeutics2022

Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19.

Marco Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.